Encompass Health Corp (EHC)

Return on equity (ROE)

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 455,700 352,000 271,000 412,200 284,200
Total stockholders’ equity US$ in thousands 2,067,000 1,647,500 1,310,300 1,911,300 1,588,000
ROE 22.05% 21.37% 20.68% 21.57% 17.90%

December 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $455,700K ÷ $2,067,000K
= 22.05%

Encompass Health Corp has demonstrated a consistent improvement in its return on equity (ROE) over the last five years. The ROE increased from 17.90% as of December 31, 2020, to 22.05% as of December 31, 2024. This upward trend indicates that the company is effectively utilizing its shareholders' equity to generate profits. A rising ROE is generally viewed positively by investors as it suggests efficient management of resources and potential for sustainable growth. Encompass Health Corp's ability to enhance its ROE reflects a strong financial performance and sound strategic decision-making, positioning the company well for continued success in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
Encompass Health Corp
EHC
22.05%
Mednax Inc
MD
-13.55%
Select Medical Holdings
SEM
12.73%